Recombinant multi-species A4GALT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine A4GALT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene catalyzes the transfer of galactose to lactosylceramide to form globotriaosylceramide, which has been identified as the P(k) antigen of the P blood group system. This protein, a type II membrane protein found in the Golgi, is also required for the synthesis of the bacterial verotoxins receptor. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
The Alternative Names of target: 4-N-acetylglucosaminyltransferase,4-galactosyltransferase,A14GALT,A4GALT,A4GALT1,A4galt,Alpha-1,Alpha4Gal-T1,CD77 synthase,Gb3,Gb3S,Globotriaosylceramide synthase (Gb3 synthase),Lactosylceramide 4-alpha-galactosyltransferase,P(k),P1,P1/Pk synthase,P1PK,PK,UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase

Target products collectionGo to A4GALT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0268-Ag-1/ GM-Tg-hg-IP0268-Ag-2 Human A4GALT protein Human
GM-Tg-rg-IP0268-Ag-1/ GM-Tg-rg-IP0268-Ag-2 Rat A4GALT protein Rat
GM-Tg-mg-IP0268-Ag-1/ GM-Tg-mg-IP0268-Ag-2 Mouse A4GALT protein Mouse
GM-Tg-cynog-IP0268-Ag-1/ GM-Tg-cynog-IP0268-Ag-2 Cynomolgus/Rhesus macaque A4GALT protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0268-Ag-1/ GM-Tg-felg-IP0268-Ag-2 Feline A4GALT protein Feline
GM-Tg-cang-IP0268-Ag-1/ GM-Tg-cang-IP0268-Ag-2 Canine A4GALT protein Canine
GM-Tg-bovg-IP0268-Ag-1/ GM-Tg-bovg-IP0268-Ag-2 Bovine A4GALT protein Bovine
GM-Tg-equg-IP0268-Ag-1/ GM-Tg-equg-IP0268-Ag-2 Equine A4GALT protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0268-Ag-1/ GM-Tg-hg-IP0268-Ag-2; GM-Tg-rg-IP0268-Ag-1/ GM-Tg-rg-IP0268-Ag-2;
GM-Tg-mg-IP0268-Ag-1/ GM-Tg-mg-IP0268-Ag-2; GM-Tg-cynog-IP0268-Ag-1/ GM-Tg-cynog-IP0268-Ag-2;
GM-Tg-felg-IP0268-Ag-1/ GM-Tg-felg-IP0268-Ag-2; GM-Tg-cang-IP0268-Ag-1/ GM-Tg-cang-IP0268-Ag-2;
GM-Tg-bovg-IP0268-Ag-1/ GM-Tg-bovg-IP0268-Ag-2; GM-Tg-equg-IP0268-Ag-1/ GM-Tg-equg-IP0268-Ag-2
Products Name A4GALT protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name A4GALT
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine A4GALT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.